registerme
Member of DD Central
Posts: 6,536
Likes: 6,332
|
Post by registerme on Dec 29, 2020 18:05:00 GMT
55k more cases in the UK today ![:(](//storage.proboards.com/forum/images/smiley/sad.png) .
|
|
michaelc
Member of DD Central
Posts: 5,463
Likes: 2,904
|
Post by michaelc on Dec 29, 2020 18:05:08 GMT
Does anyone know if we do daily test random sampling in the UK? If so, is the data produced published anywhere?
|
|
mrk
Posts: 807
Likes: 753
|
Post by mrk on Dec 29, 2020 18:10:09 GMT
Does anyone know if we do daily test random sampling in the UK? If so, is the data produced published anywhere? That would be the REACT-1 study but they only publish monthly results.
|
|
benaj
Member of DD Central
Posts: 5,421
Likes: 1,701
|
Post by benaj on Dec 29, 2020 18:39:32 GMT
Does anyone know if we do daily test random sampling in the UK? If so, is the data produced published anywhere? Well, for London, it might have just peaked before Christmas according to PHE by Specimen date. However, if schools reopen as usual in London, who knows?
|
|
james100
Member of DD Central
Posts: 1,050
Likes: 1,255
|
Post by james100 on Dec 29, 2020 19:21:54 GMT
This new variant, I'd much rather we refer to it as Boronavirus instead of VOC blah blah blah I saw it being referred to as "mutant-london-coro-coro" earlier today which was also enjoyable
|
|
michaelc
Member of DD Central
Posts: 5,463
Likes: 2,904
|
Post by michaelc on Dec 29, 2020 20:06:31 GMT
Does anyone know if we do daily test random sampling in the UK? If so, is the data produced published anywhere? That would be the REACT-1 study but they only publish monthly results. So how does anyone know even roughly how many people are likely infected? The number that is reported everywhere is the number of new positive tests. But obvisouly this depends not only on how many tests are being conducted but why they are being conducted: Selecting 10,000 people at random will give quite different results to testing people in hospital complaining of covid symptoms. I suppose there is some merit in comparing sucessive positive tests so long as everything else remains equal which it probably doesn't. Apologies if we've been through this earlier in the thread it just dawned on me whether or not these headline postivie test results are a waste of time and serve largely to worry people into following the rules?
|
|
mrk
Posts: 807
Likes: 753
|
Post by mrk on Dec 29, 2020 20:38:46 GMT
That would be the REACT-1 study but they only publish monthly results. So how does anyone know even roughly how many people are likely infected? The number that is reported everywhere is the number of new positive tests. But obvisouly this depends not only on how many tests are being conducted but why they are being conducted: Selecting 10,000 people at random will give quite different results to testing people in hospital complaining of covid symptoms. I suppose there is some merit in comparing sucessive positive tests so long as everything else remains equal which it probably doesn't. Apologies if we've been through this earlier in the thread it just dawned on me whether or not these headline postivie test results are a waste of time and serve largely to worry people into following the rules? There are different goals at play here I think. One reason to test people is so that if they're positive they're told to self-isolate and their contacts are traced, to limit the spread of the virus. That never worked very well unfortunately, but it's still one of the goals. Estimating how many people are infected is no doubt another goal, and positive tests are probably one useful - although as you point out imperfect - metric. I would guess the scientists make an estimate of how many people are actually infected by combining the daily positive tests data along with the prevalence data from that REACT-1 study. In any case, positive tests are always an underestimate of the actual number of infected, so not a particular good choice if the goal was to scare people. Personally I think the Patients in hospital numbers are actually the most important ones.
|
|
agent69
Member of DD Central
Posts: 5,956
Likes: 4,387
|
Post by agent69 on Dec 29, 2020 21:28:01 GMT
55k more cases in the UK today ![:(](//storage.proboards.com/forum/images/smiley/sad.png) . But less than half the deaths of Germany!
|
|
mrk
Posts: 807
Likes: 753
|
Post by mrk on Dec 29, 2020 21:30:42 GMT
|
|
adrianc
Member of DD Central
Posts: 9,668
Likes: 5,041
|
Post by adrianc on Dec 30, 2020 8:08:19 GMT
|
|
ilmoro
Member of DD Central
'Wondering which of the bu***rs to blame, and watching for pigs on the wing.' - Pink Floyd
Posts: 11,230
Likes: 11,420
|
Post by ilmoro on Dec 30, 2020 9:09:30 GMT
Meanwhile AZOxf vaccine licenced & roll out starts Mon
Switch to single shot program to maximize coverage, second shot 3 months later
|
|
agent69
Member of DD Central
Posts: 5,956
Likes: 4,387
|
Post by agent69 on Dec 30, 2020 9:17:51 GMT
Meanwhile AZOxf vaccine licenced & roll out starts Mon Switch to single shot program to maximize coverage, second shot 3 months later But are we getting the half dose first, or the full dose first?
|
|
jlend
Member of DD Central
Posts: 1,832
Likes: 1,461
|
Post by jlend on Dec 30, 2020 9:24:21 GMT
Meanwhile AZOxf vaccine licenced & roll out starts Mon Switch to single shot program to maximize coverage, second shot 3 months later Interesting response from Pfizer to cover themselves. In a statement, Pfizer said: "Pfizer and BioNTech's phase three study for the Covid-19 vaccine was designed to evaluate the vaccine's safety and efficacy following a two-dose schedule, separated by 21 days. "The safety and efficacy of the vaccine has not been evaluated on different dosing schedules as the majority of trial participants received the second dose within the window specified in the study design." "Pfizer says there is 'no data' its jab offers protection after first dose for more than three weeks - and says UK must monitor its efficacy." "While the trial data shows that the vaccine conferred immunity to over 50% of the participants after the first dose, marketing only one shot would require a new study in which only one dose would be administered to another set of volunteers", said BioNTech Chief Executive Uğur Şahin.
|
|
adrianc
Member of DD Central
Posts: 9,668
Likes: 5,041
|
Post by adrianc on Dec 30, 2020 9:26:59 GMT
Meanwhile AZOxf vaccine licenced & roll out starts Mon Switch to single shot program to maximize coverage, second shot 3 months later But are we getting the half dose first, or the full dose first? They're not doing the half-then-full. Insufficient evidence, according to R4 this am. My money's on it turning into a single dose, end of.
|
|
registerme
Member of DD Central
Posts: 6,536
Likes: 6,332
|
Post by registerme on Dec 30, 2020 9:38:35 GMT
Tony Blair will explode in a cloud of smug.
|
|